- Business Wire•14 hours ago
Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc, a global leader in insurance. The investment takes Owlstone Medical’s total funding to $23.5 million USD (£19.3 million GBP) since its spin-out from Owlstone Inc in 2016 and will be used to drive test adoption and commercialization of the company’s Breath Biopsy® platform. Owlstone Medical is leveraging proprietary and proven Field Asymmetric Ion Mobility Spectrometry (FAIMS) technology in its disease breathalyzer product range.
- Fool.co.uk•4 days ago
Are Lloyds Banking Group plc (LON: LLOY), Aviva plc (LON: AV) or OneSavings Bank plc (LON: OSB) attractive at present?
- Fool.co.uk•18 days ago
Would you be mad to consider selling Aviva plc (LON: AV)?
AV.L: Summary for AVIVA PLC ORD 25P - Yahoo Finance
Aviva plc (AV.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
|Bid||521.00 x 1172800|
|Ask||528.00 x 364300|
|Day's range||517.91 - 525.50|
|52-week range||290.00 - 570.50|
|PE ratio (TTM)||34.64|
|Dividend & yield||0.30 (4.44%)|
|1y target est||N/A|